Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine, Lenalidomide and Low-dose Dexamethasone (BdL) in Relapsed Multiple Myeloma
NCT01686386Phase 2Unknown
- Sponsor
- Gruppo Italiano Studio Linfomi
- Start
- Feb 2010
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in multiple myeloma (MM), sponsored by Gruppo Italiano Studio Linfomi. Status: unknown.
02
Drugs
bendamustine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01686386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01686386.